Reduced value of thallium-201 single-photon emission computed tomography in the management of HIV-related focal brain lesions in the era of highly active antiretroviral therapy

AIDS Research and Human Retroviruses

Volumn 20, Issue 6, 2004, Pages 584-588

  Giancola, Maria Letizia ^a   Rizzi, Elisa Busi ^a   Schiavo, Riccardo ^b   Lorenzini, Patrizia ^a   Schininà, Vincenzo ^a   Alba, Lucia ^a   Del Grosso, Bruno ^a   Gigli, Beniamino ^a   Rosati, Silvia ^a   Mango, Lucio ^b   Bibbolino, Corrado ^a   Antinori, Andrea ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

THALLIUM 201;

ADULT; ARTICLE; BRAIN INJURY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; ENCEPHALITIS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; ITALY; MALE; PATIENT CARE; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPECTRAL SENSITIVITY; STANDARDIZATION; TOXOPLASMOSIS;

ADULT; AIDS DEMENTIA COMPLEX; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DIAGNOSTIC TECHNIQUES, NEUROLOGICAL; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOXOPLASMOSIS, CEREBRAL;

EID: 3042642877     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/0889222041217446     Document Type: Article

References (23)

1. Ammassari A, Cingolani A, Pezzotti P, et al.: AIDS-related focal brain lesions in the era of highly active antiretroviral therapy. Neurology 2000;55:1194-1200.
2. Sacktor N, Lyles RH, Skolasky R, et al.: HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 2001;56:257-260.
3. Antinori A, Ammassari A, Cinque P, et al.: Shift of prevalence and selected characteristic in HIV-1 related neurologic disorders in HAART era: Data from Italian Register Investigative NeuroAIDS (IRINA). 8th Conference on Retroviruses and Opportunistic Infections, Chicago, IL, 2001, A8.
4. Skiest DJ: Focal neurological disease in patients with acquired immunodeficiency syndrome. Clin Infect Dis 2002;34:103-115.
5. Ciricillo SF and Rosenblum ML: Use of CT and MR imaging to distinguish intracranial lesions and to define the need for biopsy in AIDS patients. J Neurosurg 1990;73:720-724.
6. Ruiz A, Ganz WI, Post MJ, et al.: Use of thallium-201 brain SPECT to differentiate cerebral lymphoma from toxoplasma encephalitis in AIDS patients. Am J Neuroradiol 1994;15:1885-1894.
7. O'Malley JP, Ziessman HA, Kumar PN, Harkness BA, Tall JG, and Pierce PF: Diagnosis of intracranial lymphoma in patients with AIDS: Value of 201-T1 single-photon emission computed tomography encephalitis in AIDS patients. Am J Roentgenol 1994;163: 417-421.
8. 201T1 SPET for the differential diagnosis of cerebral lesions in AIDS patients. Nucl Med Commun 1997;18: 741-750.
9. 201thallium single photon emission tomography. AIDS 1997;11:1522-1523.
10. Antinori A, De Rossi G, Ammassari A, et al.: Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS-related primary CNS lymphoma. J Clin Oncol 1999;17:554-560.
11. Skiest DJ, Erdman W, Chang WE, Oz OK, Ware A, and Fleckenstein J: SPECT thallium-201 combined with Toxoplasma serology for the presumptive diagnosis of focal central nervous system mass lesions in patients with AIDS. J Infect 2000;40:274-281.
12. Cinque P, Scarpellini P, Vago L, Linde A, and Lazzarin A: Diagnosis of central nervous system complications in HIV-infected patients: Cerebrospinal fluid analysis by the polymerase chain reaction. AIDS 1997;11:1-17.
13. Cingolani A, De Luca A, Larocca LM, et al.: Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary central nervous system lymphoma. J Natl Cancer Inst 1998;90: 364-369.
14. Evaluation and management of intracranial lesions in AIDS. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1998;50:21-26.
15. Fournier S, Rabian C, Alberti C, et al.: Immune recovery under highly active antiretroviral therapy is associated with restoration of lymphocyte proliferation and interferon-γ production in the presence of Toxoplasma gondii antigens. J Infect Dis 2001;183:1586-1591.
16. Jenny-Avital ER and Abadi M: Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy. Clin Infect Dis 2002;35:128-133.
17. Cinque P, Bossolasco P, Brambilla AM, et al.: The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: Study of 43 cases with review of the literature. J Neurovirol 2003;9(Suppl. 1):73-80.
18. Iranzo A, Marti-Fabregas J, Domingo P, et al.: Absence of thallium-201 brain uptake in progressive multifocal leukoencephalopathy in AIDS patients. Acta Neurol Scand 1999;100:102-105.
19. Ammassari A, Lorenzini P, Cinque P, et al., for the Italian Registry Investigative NeuroAIDS (IRINA): Encephalopathy of unknown origin (EUO): A new picture in the era of HAART? 9th Conference on Retroviruses and Opportunistic Infections, Seattle, WA, 2002, A730W.
20. Langford TD, Letendre SL, Marcotte TD, et al.: Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS 2002;16:1019-1029.
21. Antinori A, Ammassari A, Luzzati R, et al.: Role of brain biopsy in the management of focal brain lesions in HIV-infected patients. Neurology 2002;54:993-997.
22. Abgrall A, Rabaud C, Costagliola D, and the Clinical Epidemiology Group of the French Hospital Database on HIV: Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era. Clin Infect Dis 2001;33:1747-1755.
23. Antinori A, Ammassari A, De Luca A, et al.: Diagnosis of AIDS-related focal brain lesions: A decision making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology 1997;48:687-694.